About
Elaia is a Paris-based independent venture capital firm founded in 2002 by Philippe Gire and Xavier Lazarus, with more than 700 million euros under management. The firm focuses on digital economy and deep tech investments across Europe and has strong connections to French research institutions, including INRIA and PSL. Elaia is a prominent investor in the French quantum computing ecosystem. It led the Series A funding for Alice & Bob, which develops quantum error correction using bosonic cat qubits, in a 27 million euro round, and continued as an existing investor through the company's 100 million euro Series B in January 2025. The firm also backed AQEMIA, an AI-driven drug discovery company from PSL labs. In 2024, Elaia launched a new deep tech fund with a 120 million euro target, with quantum computing as a key investment theme. Elaia's strategy relies on deep partnerships with academic institutions including INRIA, which help it identify quantum startups early as they emerge from research. The firm invests from pre-seed through Series B, and its portfolio has produced 3 unicorns, 4 IPOs, and 57 acquisitions.
Quantum Specifications
| Quantum Focus | hardware |